Serum Total Bilirubin, not Cholelithiasis, is Influenced by UGT1A1 Polymorphism, Alpha Thalassemia and βs Haplotype: First Report on Comparison between Arab-Indian and African βs Genes

被引:10
|
作者
Alkindi, Said Y. [1 ]
Pathare, Anil [2 ]
Al Zadjali, Shoaib [2 ]
Panjwani, Vinodhkumar [2 ]
Wasim, Fauzia [2 ]
Khan, Hammad [2 ]
Chopra, Pradeep [2 ]
Krishnamoorthy, Rajagopal [3 ,4 ]
Alkindi, Salam [5 ]
机构
[1] McMaster Univ, Minist Hlth, Hamilton, ON, Canada
[2] Sultan Qaboos Univ Hosp, Muscat, Oman
[3] INSERM, U665, F-75015 Paris, France
[4] Lab Excellence GR EX, Paris, France
[5] Sultan Qaboos Univ, Coll Med & Hlth Sci, Muscat, Oman
来源
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2015年 / 7卷
关键词
SICKLE-CELL-ANEMIA; 1A PROMOTER POLYMORPHISMS; HB-F; DISEASE; ASSOCIATION; PREVALENCE; GALLSTONES; REGION;
D O I
10.4084/MJHID.2015.060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We explored the potential relationship between steady state serum bilirubin levels and the incidence of cholelithiasis in the context of UGT1A1 gene A(TA)nTAA promoter polymorphism in Omani sickle cell anemia (SCA) patients, homozygotes for African (Benin and Bantu) and Arab-Indian beta(S) haplotypes, but sharing the same microgeographical environment and comparable life style factors. Methods: 136 SCA patients were retrospectively studied in whom imaging data including abdominal CT scan, MRI or Ultrasonography were routinely available. Available data on the mean steady state hematological/biochemical parameters (n=136), beta(s) haplotypes(n=136), alpha globin gene status (n=105) and UGT1A1 genotypes (n=133) were reviewed from the respective medical records. Results: The mean serum total bilirubin level was significantly higher in the homozygous UGT1A1(AT)(7) group as compared to UGT1A1(AT)(6) group. Thus, not cholelithiasis but total serum bilirubin was influenced by UGT1A1 polymorphism in this SCA cohort. Conclusion: As observed in other population groups, the UGT1A1 (AT)(7) homozygosity was significantly associated with raised serum total bilirubin level, but the prevalence of gallstones in the Omani SCA patients was not associated with. thalassaemia, UGT1A1 polymorphism, or beta(s) haplotypes.
引用
收藏
页数:7
相关论文
共 3 条
  • [1] Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort
    Batista, Jessica V. G. F.
    Arcanjo, Gabriela S.
    Batista, Thais H. C.
    Sobreira, Marcondes J.
    Santana, Rodrigo M.
    Domingos, Igor F.
    Hatzlhofer, Betania L.
    Falcao, Diego A.
    Pereira-Martins, Diego A.
    Oliveira, Jessica M.
    Araujo, Amanda S.
    Laranjeira, Luana P. M.
    Medeiros, Fernanda S.
    Albuquerque, Flavia P.
    Albuquerque, Dulcineia M.
    Santos, Magnun N.
    Hazin, Manuela F.
    dos Anjos, Ana C.
    Costa, Fernando F.
    Araujo, Aderson S.
    Lucena-Araujo, Antonio R.
    Bezerra, Marcos A.
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 903 - 911
  • [2] Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort
    Jéssica V. G. F. Batista
    Gabriela S. Arcanjo
    Thais H. C. Batista
    Marcondes J. Sobreira
    Rodrigo M. Santana
    Igor F. Domingos
    Betânia L. Hatzlhofer
    Diego A. Falcão
    Diego A. Pereira-Martins
    Jéssica M. Oliveira
    Amanda S. Araujo
    Luana P. M. Laranjeira
    Fernanda S. Medeiros
    Flávia P. Albuquerque
    Dulcinéia M. Albuquerque
    Magnun N. Santos
    Manuela F. Hazin
    Ana C. dos Anjos
    Fernando F. Costa
    Aderson S. Araujo
    Antonio R. Lucena-Araujo
    Marcos A. Bezerra
    Annals of Hematology, 2021, 100 : 903 - 911
  • [3] Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?
    de Azevedo, Laura Alencastro
    Bonazzoni, Joyce
    Wagner, Sandrine Comparsi
    Farias, Mariela Granero
    Bittar, Christina M.
    Daudt, Liane
    de Castro, Simone Martins
    MOLECULAR DIAGNOSIS & THERAPY, 2017, 21 (04) : 437 - 442